- Report
- July 2025
- 204 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 381 Pages
Global
From €3720EUR$4,197USD£3,234GBP
- Report
- December 2024
- 427 Pages
Global
From €4388EUR$4,950USD£3,814GBP
- Report
- September 2024
- 154 Pages
Global
From €1994EUR$2,250USD£1,734GBP
- Report
- October 2024
- 191 Pages
Global
From €2172EUR$2,450USD£1,888GBP
- Report
- May 2025
- 196 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 181 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 199 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 184 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 193 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- March 2025
- 120 Pages
Global
From €5274EUR$5,950USD£4,585GBP
- Report
- October 2024
- 150 Pages
Global
From €5274EUR$5,950USD£4,585GBP
- Report
- March 2025
- 241 Pages
Global
From €3989EUR$4,500USD£3,468GBP
- Report
- February 2025
- 217 Pages
Global
From €3590EUR$4,050USD£3,121GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more